| Meeting Brochure and registration form SMDM Homepage | |
|
|
|
||||
| Monday, 24 October 2005: 7:00 AM-8:30 AM | |||
| Pacific Room EFG (Hyatt Regency San Francisco) | |||
| Poster Session III | |||
| Part 1 | |||
| 1 | CAN THE USE OF PROPHYLACTIC PEGFILGRASTIM REDUCE THE COST OF CANCER TREATMENT? Adi Eldar-Lissai, MBA, Leon E. Cosler, Ph.D., R.Ph., Gary H. Lyman, M.D., M.P.H. | ||
| 2 | EFFECT OF PHYSICIAN INFORMATION STYLE AND IMPLEMENTATION STRATEGY ON GUIDELINE ADHERENCE Lee Green, MD, MPH, Christine Kowalski, MS, Sarah Krein, PhD, RN, Julie Lowery, PhD, Leon Wyszewianski, PhD | ||
| 3 | AN EVIDENCE-BASED GUIDELINE FOR COLORECTAL CANCER SCREENING IN AVERAGE-RISK ADULTS Theodore R. Levin, MD, Marguerite A. Koster, MA, MFT, Wiley Chan, MD, Karin L. Kempe, MD | ||
| 4 | VALIDATION AND UPDATING OF A PREDICTION RULE FOR SEVERE POSTOPERATIVE PAIN Kristel J.M. Janssen, MSc, C.J. Kalkman, PhD, MD, K.G.M. Moons, PhD, Diederick E. Grobbee, PhD, MD, Gouke J. Bonsel, MD, PhD, Y. Vergouwe, PhD | ||
| 6 | COST EFFECTIVENESS OF TREATING THE METABOLIC SYNDROME IN THE AFRICAN AMERICAN AND GENERAL POPULATION Joseph T. Tasosa, MBA, MS, John McAlearney, PhD, Richard J. Schuster, MD, MMM | ||
| 7 | COST-EFFECTIVENESS OF DRUG ELUTING STENTS Torbjørn Wisløff, M.Sc., Inger N. Norderhaug, Ph.D., Nils-Einar Kløw, MD, PhD, Svein Rotevatn, PhD, Ivar S.ønbø Kristiansen, PhD | ||
| 8 | THE COST EFFECTIVENESS OF AN OUTREACH INTERVENTION FOR WOMEN WITH ABNORMAL PAP SMEARS Todd H. Wagner, PhD, Linda P. Engelstad, MD, Stephen J. McPhee, MD, Rena J. Pasick, Dr., PH | ||
| 9 | COST-EFFECTIVENESS OF SURGICAL RESECTION COMPARED WITH LOCAL ABLATION FOR INITIAL TREATMENT OF SOLITARY SMALL HEPATOCELLULAR CARCINOMA WITH HCV HEPATITIS OR CIRRHOSIS Haku Ishida, MD, PhD, Keisuke Hino, MD, PhD, Fumie Kurokawa, MD, PhD, Souji Nishina, MD, Kiwamu Okita, MD, PhD, Yuji Inoue, MD, PhD | ||
| Part 2 | |||
| 10 | ASSESSING COST-EFFECTIVENESS AND VALUE CREATION FOR TARGETED THERAPY IN NON-SMALL CELL LUNG CANCER David L. Veenstra, PharmD, PhD, Beidler Henrikson, MPH, Lou Garrison, PhD, Scott Ramsey, MD, PhD | ||
| Part 3 | |||
| 11 | THE COST-EFFECTIVENESS OF ANTIBIOTIC USE AT SURGICAL ABORTION BY AGE AND DESIRE FOR FUTURE CHILDBEARING Matthew F. Reeves, MD, Kenneth J. Smith, MD, Mitchell D. Creinin | ||
| 12 | COST-EFFECTIVENESS ANALYSIS OF RISPERIDONE LONG ACTING INJECTION (RISPERDAL CONSTA®) FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA WHO ARE PARTIALLY MEDICATION ADHERENT IN AUSTRALIA Rudolf Schrover, MSc, Steven Crowley, MA, MBA, Munro Neville, MBBS, MBA, MSc | ||
| Part 4 | |||
| 13 | DEVELOPING GUIDELINES FOR PRIMARY ASYMPTOMATIC HYPERPARATHYROIDISM MANAGEMENT: USEFULNESS OF A COST-EFFECTIVENESS ANALYSIS K. Sejean, S. Calmus, I. Durand-Zaleski, MD, PhD, GM Vidal-Trecan, MD, PhD | ||
| 14 | EFFECTS OF PATIENT SELF-SELECTION ON COST-EFFECTIVENESS: IMPLICATIONS FOR INTENSIVE THERAPY FOR DIABETES David O. Meltzer, MD, PhD, Elbert S. Huang, MD, MPH, Sydney E.S. Brown, BA, Qi Zhang, PhD | ||
| Part 5 | |||
| 15 | EQUILIBRIUM POPULATION METHODS FOR MARKOV MODELS OF HEALTH INTERVENTIONS Gordon B. Hazen, PhD, Min Huang | ||
| 16 | THE COST-EFFECTIVENESS OF ALTERNATIVE STRATEGIES FOR THE MANAGEMENT OF CHRONIC NON-MALIGNANT PAIN: BAYESIAN EVIDENCE SYNTHESIS AND PROBABILISTIC DECISION MODEL Neil Hawkins, MSc, Mark Sculpher, PhD, James Morris, MPH | ||
| 17 | INFLUENCE OF EXPECTATION OF COMPENSATION ON QUALITY OF LIFE John A. Myers, PhD, Stephan F. Gohmann, PhD | ||
| 18 | METHODOLOGICAL QUALITY OF COST-EFFECTIVENESS ANALYSES OF SUGICAL PROCEDURES Seema S. Sonnad, PhD, Jibby E. Kurichi, MPH, Laura Kruper, MD | ||
| Part 6 | |||
| 19 | ELEPHANT NODES SAVE THE DAY: MORE EFFICIENT COST EFFECTIVENESS EVALUATION OF STRATEGIES INVOLVING EMBEDDED DECISIONS C. Greg Hagerty, PhD, Gillian D. Sanders, PhD, Frank A. Sonnenberg, MD | ||
| Part 7 | |||
| 19 | METHODOLOGICAL ISSUES IN COST EFFECTIVENESS EVALUATION OF HEPATITIS A VACCINE: A SYSTEMATIC REVIEW Andrea Anonychuk, MSc, Andrea C. Tricco, MSc, Chris Bauch, PhD, Vladimir Gilca, MD, Bernard Duval, MD, MPH, Ba Pham, MSc, Murray Krahn, MD, MSc | ||
| 20 | CONSTRUCTION AND INTERNAL VALIDATION OF A MARKOV MODEL FOR COST-EFFECTIVENESS Lois G. Kim, MSc, Helen E. Campbell, MSc, Martin J. Buxton, BA, Andrew Briggs, DPhil, Simon G. Thompson, DSc | ||
| 21 | ABSENTEEISM FROM WORK: THE EXPERIENCE OF EMPLOYED BREAST AND PROSTATE CANCER PATIENTS 6 MONTHS FOLLOWING DIAGNOSIS Cathy J. Bradley, PhD, Kathleen Oberst, MS, Maryjean Schenk, MD | ||
| 22 | IMPACT OF OBESITY ON WORKFORCE PARTICIPATION AMONG U.S. ADULTS Kaan Tunceli, PhD, Kemeng Li, MA, L.Keoki Williams, MD, MPH | ||
| 23 | ESTIMATION OF THE ECONOMIC CAPACITY OF SIMULATED MASS INFLUENZA VACCINATION CLINICS: COST FUNCTION ESTIMATION APPROACH Bo-Hyun Cho, PhD, Mark Messonnier, MS, PhD, Michael Washington, PhD | ||
| 24 | EVALUATION OF ALGORITHMS TO IDENTIFY BREAST CANCER CASES IN MEDICARE CLAIMS DATA Heather Taffet Gold, PhD, Huong T. Do, MA | ||
| 25 | HOW COVERAGE DECISIONS INFLUENCE HEALTH CARE Kathryn Phillips, PhD, Su-Ying Liang, PhD, Uri Ladabaum, MD, Jennifer Haas, MD, Mika Nagamine, PhD, Stephanie Van Bebber, MSc, Robert A. Hiatt, MD, PhD, Karla Kerlikowske, MD, MPH | ||
| 26 | USE OF AGGRESSIVE MEDICAL TREATMENTS NEAR THE END OF LIFE: DIFFERENCES BETWEEN PATIENTS WITH AND WITHOUT DEMENTIA Samuel S. Richardson, BA, Greer Sullivan, MD, MSPH, Ariel K. Hill, AB, Wei Yu, PhD | ||
| 27 | COSTS ASSOCIATED WITH DISEASE SEVERITY IN SIX SELECTED CHRONIC DISEASES IN MANAGED CARE SETTINGS Kristina S. Chen, PharmD, MS, Eileen B. Reyes, BS, George A. Goldberg, MD, Robert W. Dubois, MD, PhD | ||
| 28 | ANALYSIS OF CORE CONCEPTS WITHIN THE SOCIETY OF MEDICAL DECISION MAKING Elissa M. Ozanne, PhD, James Stahl, MD, CM, MPH | ||
| Part 8 | |||
| 29 | DECISION AIDS FOR PSA SCREENING: IS IT JUST A SIMPLE BLOOD TEST? Vibha Bhatnagar, MD, MPH, Dominick L. Frosch, PhD, Steven Tally, PhD, Robert M. Kaplan, PhD | ||
| Part 9 | |||
| 30 | COST-EFFECTIVENESS AND COST-BENEFIT OF SCREENING NEWBORNS FOR CONGENITAL ADRENAL HYPERPLASIA: DIFFERENT METHODS, DIFFERENT ANSWERS? Byung-Kwang Yoo, MD, PhD, Scott D. Grosse, PhD | ||
| 31 | TRANSLATING NEW ICD-9 CODES INTO PRACTICE FOR IMPROVED DECISION MAKING Judith J. Baker, PhD, MA, MS, Christopher J. Panarites, PhD | ||
| 32 | DEVELOPMENT AND PILOT TESTING OF A COMPOSITE SCALE IN STRESS URINARY INCONTINENCE TO ASSESS THERAPEUTIC RESPONSE IN CLINICAL PRACTICE AND CLINICAL RESEARCH Benoit Arnould, MSc, MA, Brigitte Bosio-Le Goux, Nadia Cadi-Soussi, Catherine Droumaguet, Nathalie Heurtebize, Pierre Costa | ||
| 33 | EXPERT OPINION IN VALUE OF INFORMATION ASSESSMENT M. P. Janssen, E. Buskens | ||
| Part 10 | |||
| 34 | NEW INSTRUMENTS TO MEASURE DECISION QUALITY FOR BREAST CANCER Karen R. Sepucha, PhD, Elissa M. Ozanne, PhD, Kevin Hughes, MD, FACS, Kerry A. Farrelly, BS, Ann Partridge, MD, MPH, Albert Mulley, MD | ||
| Part 11 | |||
| 35 | RELATIONSHIPS AMONG PATIENTS' PROGNOSTIC ESTIMATES, MOOD STATES AND THEIR INFORMATION PROCESSING STYLES Melissa Cappaert, MA, Neal V. Dawson, MD, Charles Thomas, Julia H. Rose | ||
| Part 12 | |||
| 36 | USING FRACTIONAL FACTORIAL DESIGNS TO UNTANGLE THE EFFECTS OF PATIENT DECISION AIDS Angela Fagerlin, PhD, Vijay Nair, Brian J. Zikmund-Fisher, PhD, Dylan M. Smith, PhD, Peter A. Ubel, MD | ||
| 37 | DECISION MODEL FOR INFORMATION AND COMMUNICATION TECHNOLOGY IMPLICATIONS IN HEALTH SERVICE: USER PERCEPTION Astrid M. Oddershede, Msc, Rolando A. Carrasco, PhD, Ismael Soto, PhD | ||
| Part 13 | |||
| 38 | TAMING TABLE 1: MAKING MODELING ASSUMPTIONS MORE TRANSPARENT THROUGH A SENSITIVITY ANALYSIS BASED ON STRENGTH OF EVIDENCE R. Scott Braithwaite, MD, MSc, Amy C. Justice, MD, PhD, Mark S. Roberts, MD, MPP | ||
| 39 | CHOOSING BETWEEN CADAVERIC AND LIVING-DONOR LIVERS: A MARKOV DECISION PROCESS (MDP) MODEL APPROACH Oguzhan Alagoz, PhD, Lisa Maillart, PhD, Andrew Schaefer, PhD, Mark S. Roberts, MD | ||
| 40 | QUANTIFICATION OF DIAGNOSTIC TEST DISCRIMINATION AND CALIBRATION IN UNITS OF BITS OF INFORMATION William A. Benish, MD, MS, Matthew Karafa, PhD, Neal V. Dawson, MD | ||
| Part 14 | |||
| 41 | MODELING RESOURCES NEEDED TO IMPROVE COLORECTAL CANCER SCREENING RATES Susan I. Bachman, PhD, Theodore R. Levin, MD, Bernadette B. Santamaria, MPH | ||
| Part 15 | |||
| 42 | DECISION SUPPORT: THE PATIENT VIEW Cherrill Hicks, Amanda Hoey | ||
| Part 16 | |||
| 43 | PERCEIVED EVIDENCE BASE AND LEADERSHIP ATTITUDES TOWARD SCREENING COLONOSCOPY Laura Kochevar, PhD, Vikas Khurana, MD | ||
| Part 17 | |||
| 44 | ETHNIC DIFFERENCES IN WTP FOR IMPROVEMENTS IN OSTEOARTHRITIS AMONG PATIENTS WITH OSTEOARTHRITIS Margaret M. Byrne, PhD, Julianne Souchek, PhD, Marsha Richardson, MSW, Maria E. Suarez-Almazor, MD, PhD | ||
| 45 | MIXED MESSAGES: WHAT HEALTHCARE PROVIDERS SAY AND WHAT PATIENTS HEAR ABOUT ALCOHOL CONSUMPTION AND HEPATITIS C (HCV) Carol E. Blixen, PhD, RN, Noah Webster, MS, Andrew Hund, MS, Adam Perzynski, MA, Joshua Terchek, BA, Stephanie Kanuch, MEd, Eleanor P. Stoller, PhD, Richard McCormack, PhD, Neal V. Dawson, MD | ||
| Part 18 | |||
| 46 | PHYSICIANS' RISK COMMUNICATION ABOUT TOXIC CHEMICAL EXPOSURE Noel T. Brewer, PhD, Nancy Fiedler, PhD, Michael Gochfeld, MD, Howard M. Kipen | ||
| 48 | SENSITIVITY AND SPECIFICITY OF VARIOUS APPROACHES TO DETERMINING A THRESHOLD FOR RESPONDER ANALYSIS Dorcas E. Beaton, PhD, Dwayne Van Eerd, MSc, Anusha Raj, Anjali Mazumder, Peter Smith, Gabrielle van der Velde, Kimberley Cullen | ||
| Part 19 | |||
| 48 | RISK ATTITUDES AMONG PATIENTS WITH HIV, HEPATITIS C AND HIV/HEPATITIS C CO-INFECTION: HOW DO THEY COMPARE WITH EACH OTHER AND WITH THOSE OF PRIMARY CARE HOUSE OFFICERS? Caitlin M. Giesler, M.D., Michael S. Yi, M.D., Joseph M. Mrus, M.D., Anthony C. Leonard, PhD, Sara E. Luckhaupt, M.D., Joel Tsevat, M.D. | ||
| 49 | DO WOMEN FAVOR ONE VALUES CLARIFICATION TECHNIQUE OVER ANOTHER? A PRELIMINARY COMPARATIVE STUDY Hilary A. Llewellyn-Thomas, PhD, Caroline Moore, MS, Nathan Gile, MBA | ||
| 50 | WHAT DO AFRICAN AMERICAN AND CAUCASIAN MEN SAY THEY CONSIDER IN MAKING PROSTATE CANCER TREATMENT DECISIONS? A QUALITATIVE STUDY OF TREATMENT ATTRIBUTES Sara J. Knight, PhD, David M. Latini, Ph.D., Mary-Margaret Chren, MD | ||
| 51 | USING ECONOMIC EVIDENCE TO PRIORITIZE SUBGROUPS DURING AN INFLUENZA VACCINE SHORTAGE Lisa A. Prosser, PhD, Marie R. Griffin, MD, MPH, Ron Keren, MD, MPH, Martin I. Meltzer, PhD, Ismael R. Ortega-Sanchez, MS, PhD, Guillermo A. Herrera, MD, MBA, Mark Messonnier, MS, PhD, Carolyn Buxton Bridges, MD | ||
| 52 | THYROID SCREENING IS APPROPRIATE ... SOMETIMES Gay J. Canaris, MD, MSPH, Robert S. Wigton, MD, MS | ||
| 53 | A NOVEL APPROACH TO CAPTURE BOTH THE INDIVIDUAL- AND POPULATION-LEVEL EFFECTS OF HIV SCREENING A. David Paltiel, PhD, Rochelle P. Walensky, MD, MPH, Bruce R. Schackman, PhD, George R. Seage III, DSc, MPH, Milton C. Weinstein, PhD, Kenneth A. Freedberg, MD, MSc | ||
| Part 20 | |||
| 54 | CERVICAL CANCER SCREENING: POTENTIAL COST-EFFECTIVENESS OF TECHNOLOGY TO IMPROVE COLPOSCOPY AND BIOPSY PERFORMANCE Steven G. Sweet, MBA, Jane J. Kim, MS, Thomas C. Wright, MD, Sue J. Goldie, MD, MPH | ||
| Part 21 | |||
| 55 | MARKOV MODELING OF MAJOR DEPRESSION DYNAMICS Robert C. Lee, Scott Patten, MD, PhD | ||
| 56 | THE EFFECTIVENESS ANALYSIS OF A BEHAVIORAL HIV RISK REDUCTION INTERVENTION: A STUDY FROM AN EXCEL-BASED MONTE CARLO SIMULATION MODEL Sada Soorapanth, PhD, Stephanie Sansom, PhD, Stephen Chick, PhD | ||
| Part 22 | |||
| 57 | EVALUATING THE PHARMACOGENOMICS BIAS IN DECISION-ANALYTIC MODELING Uwe Siebert, MD, MPH, SM, ScD, Sue J. Goldie, MD, MPH, Milton C. Weinstein, PhD, Karen M. Kuntz, ScD | ||
| Part 23 | |||
| 58 | HOW GOOD DO ORGAN REPLACEMENT TECHNOLOGIES NEED TO BE: VOLUME AND DURABILITY James Stahl, MD, CM, MPH, Joseph Vacanti, MD | ||
| 59 | VARIATION IN RISK FACTORS INCLUDED IN CANCER RISK CALCULATIONS ON THE WEB Andrea D. Gurmankin, PhD, MBe, Seema S. Sonnad, PhD, Jibby E. Kurichi, MPH, Katrina Armstrong, M.D., M.S. | ||
| 60 | DIAGNOSTIC PERFORMANCE OF DUPLEX ULTRASOUND IN PATIENTS SUSPECTED OF CAROTID ARTERY DISEASE: THE IPSILATERAL VERSUS CONTRALATERAL ARTERY Majanka H. Heijenbrok-Kal, PhD, Paul J. Nederkoorn, MD, PhD, Erik Buskens, MD, PhD, Yolanda Van der Graaf, MD, PhD, M.G. Myriam Hunink, MD, PhD | ||
See more of The 27th Annual Meeting of the Society for Medical Decision Making (October 21-24, 2005)
Papers submitted for the Lee B. Lusted Student Prize Competition are denoted with an asterisk (*)